482 related articles for article (PubMed ID: 21298015)
41. One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model.
Rai A; Pinto S; Velho TR; Ferreira AF; Moita C; Trivedi U; Evangelista M; Comune M; Rumbaugh KP; Simões PN; Moita L; Ferreira L
Biomaterials; 2016 Apr; 85():99-110. PubMed ID: 26866877
[TBL] [Abstract][Full Text] [Related]
42. Two optimized antimicrobial peptides with therapeutic potential for clinical antibiotic-resistant Staphylococcus aureus.
Li C; Zhu C; Ren B; Yin X; Shim SH; Gao Y; Zhu J; Zhao P; Liu C; Yu R; Xia X; Zhang L
Eur J Med Chem; 2019 Dec; 183():111686. PubMed ID: 31520928
[TBL] [Abstract][Full Text] [Related]
43. Development of an Experimental Ex Vivo Wound Model to Evaluate Antimicrobial Efficacy of Topical Formulations.
Andersson MÅ; Madsen LB; Schmidtchen A; Puthia M
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068733
[TBL] [Abstract][Full Text] [Related]
44. A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound-healing properties.
Kasus-Jacobi A; Noor-Mohammadi S; Griffith GL; Hinsley H; Mathias L; Pereira HA
J Leukoc Biol; 2015 Feb; 97(2):341-50. PubMed ID: 25412625
[TBL] [Abstract][Full Text] [Related]
45. An Overview of Frog Skin-Derived Esc Peptides: Promising Multifunctional Weapons against
Mangoni ML; Loffredo MR; Casciaro B; Ferrera L; Cappiello F
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673985
[TBL] [Abstract][Full Text] [Related]
46. Novel antimicrobial peptides identified in legume plant,
Alhhazmi AA; Alluhibi SS; Alhujaily R; Alenazi ME; Aljohani TL; Al-Jazzar A-AT; Aljabri AD; Albaqami R; Almutairi D; Alhelali LK; Albasri HM; Almutawif YA; Alturkostani MA; Almutairi AZ
Microbiol Spectr; 2024 Feb; 12(2):e0182723. PubMed ID: 38236024
[TBL] [Abstract][Full Text] [Related]
47. Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs.
Mohamed MF; Hammac GK; Guptill L; Seleem MN
PLoS One; 2014; 9(12):e116259. PubMed ID: 25551573
[TBL] [Abstract][Full Text] [Related]
48. Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity.
Papareddy P; Kalle M; Sørensen OE; Lundqvist K; Mörgelin M; Malmsten M; Schmidtchen A
PLoS One; 2012; 7(12):e52772. PubMed ID: 23300768
[TBL] [Abstract][Full Text] [Related]
49. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.
Deslouches B; Phadke SM; Lazarevic V; Cascio M; Islam K; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2005 Jan; 49(1):316-22. PubMed ID: 15616311
[TBL] [Abstract][Full Text] [Related]
50. A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model.
Yuan Y; Zai Y; Xi X; Ma C; Wang L; Zhou M; Shaw C; Chen T
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):849-856. PubMed ID: 30802593
[TBL] [Abstract][Full Text] [Related]
51. Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.
Leszczyńska K; Namiot A; Cruz K; Byfield FJ; Won E; Mendez G; Sokołowski W; Savage PB; Bucki R; Janmey PA
J Appl Microbiol; 2011 Jan; 110(1):229-38. PubMed ID: 20961363
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.
Wu X; Wang Z; Li X; Fan Y; He G; Wan Y; Yu C; Tang J; Li M; Zhang X; Zhang H; Xiang R; Pan Y; Liu Y; Lu L; Yang L
Antimicrob Agents Chemother; 2014 Sep; 58(9):5342-9. PubMed ID: 24982064
[TBL] [Abstract][Full Text] [Related]
53. A novel antimicrobial peptide Scyreptin
Zhang W; An Z; Bai Y; Zhou Y; Chen F; Wang KJ
Biochem Pharmacol; 2023 Dec; 218():115917. PubMed ID: 37952897
[TBL] [Abstract][Full Text] [Related]
54. Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.
Taira J; Kida Y; Yamaguchi H; Kuwano K; Higashimoto Y; Kodama H
J Pept Sci; 2010 Nov; 16(11):607-12. PubMed ID: 20648478
[TBL] [Abstract][Full Text] [Related]
55. Thymic stromal lymphopoietin exerts antimicrobial activities.
Sonesson A; Kasetty G; Olin AI; Malmsten M; Mörgelin M; Sørensen OE; Schmidtchen A
Exp Dermatol; 2011 Dec; 20(12):1004-10. PubMed ID: 22092577
[TBL] [Abstract][Full Text] [Related]
56. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
Deslouches B; Islam K; Craigo JK; Paranjape SM; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2005 Aug; 49(8):3208-16. PubMed ID: 16048927
[TBL] [Abstract][Full Text] [Related]
57. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
58. Salt-resistant short antimicrobial peptides.
Mohanram H; Bhattacharjya S
Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911
[TBL] [Abstract][Full Text] [Related]
59. Controlling methicillin resistant Staphyloccocus aureus and Pseudomonas aeruginosa wound infections with a novel biomaterial.
Martineau L; Davis SC; Peng HT; Hung A
J Invest Surg; 2007; 20(4):217-27. PubMed ID: 17710602
[TBL] [Abstract][Full Text] [Related]
60. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
